298 related articles for article (PubMed ID: 29928692)
1. X chromosome protects against bladder cancer in females via a
Kaneko S; Li X
Sci Adv; 2018 Jun; 4(6):eaar5598. PubMed ID: 29928692
[TBL] [Abstract][Full Text] [Related]
2.
Kobatake K; Ikeda KI; Nakata Y; Yamasaki N; Ueda T; Kanai A; Sentani K; Sera Y; Hayashi T; Koizumi M; Miyakawa Y; Inaba T; Sotomaru Y; Kaminuma O; Ichinohe T; Honda ZI; Yasui W; Horie S; Black PC; Matsubara A; Honda H
Clin Cancer Res; 2020 Apr; 26(8):2065-2079. PubMed ID: 32047002
[TBL] [Abstract][Full Text] [Related]
3. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
Ler LD; Ghosh S; Chai X; Thike AA; Heng HL; Siew EY; Dey S; Koh LK; Lim JQ; Lim WK; Myint SS; Loh JL; Ong P; Sam XX; Huang D; Lim T; Tan PH; Nagarajan S; Cheng CW; Ho H; Ng LG; Yuen J; Lin PH; Chuang CK; Chang YH; Weng WH; Rozen SG; Tan P; Creasy CL; Pang ST; McCabe MT; Poon SL; Teh BT
Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228601
[TBL] [Abstract][Full Text] [Related]
4. KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1.
Liu L; Cui J; Zhao Y; Liu X; Chen L; Xia Y; Wang Y; Chen S; Sun S; Shi B; Zou Y
Mol Cancer; 2021 May; 20(1):77. PubMed ID: 34006303
[TBL] [Abstract][Full Text] [Related]
5. Significance of KDM6A mutation in bladder cancer immune escape.
Chen X; Lin X; Pang G; Deng J; Xie Q; Zhang Z
BMC Cancer; 2021 May; 21(1):635. PubMed ID: 34051747
[TBL] [Abstract][Full Text] [Related]
6. Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality.
Watanabe S; Shimada S; Akiyama Y; Ishikawa Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Int J Cancer; 2019 Jul; 145(1):192-205. PubMed ID: 30556125
[TBL] [Abstract][Full Text] [Related]
7. Intravesical delivery of
Kong N; Zhang R; Wu G; Sui X; Wang J; Kim NY; Blake S; De D; Xie T; Cao Y; Tao W
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35131941
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
Biochem Biophys Res Commun; 2017 Sep; 490(4):1407-1413. PubMed ID: 28698146
[TBL] [Abstract][Full Text] [Related]
9. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
Nickerson ML; Dancik GM; Im KM; Edwards MG; Turan S; Brown J; Ruiz-Rodriguez C; Owens C; Costello JC; Guo G; Tsang SX; Li Y; Zhou Q; Cai Z; Moore LE; Lucia MS; Dean M; Theodorescu D
Clin Cancer Res; 2014 Sep; 20(18):4935-48. PubMed ID: 25225064
[TBL] [Abstract][Full Text] [Related]
10. The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity.
Itoh Y; Golden LC; Itoh N; Matsukawa MA; Ren E; Tse V; Arnold AP; Voskuhl RR
J Clin Invest; 2019 Aug; 129(9):3852-3863. PubMed ID: 31403472
[TBL] [Abstract][Full Text] [Related]
11. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
12. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
13. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
[TBL] [Abstract][Full Text] [Related]
14. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.
Qiu H; Makarov V; Bolzenius JK; Halstead A; Parker Y; Wang A; Iyer GV; Wise H; Kim D; Thayaparan V; Lindner DJ; Haber GP; Ting AH; Ren B; Chan TA; Arora V; Solit DB; Lee BH
Cancer Res; 2023 Mar; 83(6):814-829. PubMed ID: 36638328
[TBL] [Abstract][Full Text] [Related]
15. Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.
Gažová I; Lengeling A; Summers KM
Mol Genet Metab; 2019 May; 127(1):31-44. PubMed ID: 31097364
[TBL] [Abstract][Full Text] [Related]
16. Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer.
Barrows D; Feng L; Carroll TS; Allis CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25732-25741. PubMed ID: 32989154
[TBL] [Abstract][Full Text] [Related]
17. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
18. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Hurst CD; Alder O; Platt FM; Droop A; Stead LF; Burns JE; Burghel GJ; Jain S; Klimczak LJ; Lindsay H; Roulson JA; Taylor CF; Thygesen H; Cameron AJ; Ridley AJ; Mott HR; Gordenin DA; Knowles MA
Cancer Cell; 2017 Nov; 32(5):701-715.e7. PubMed ID: 29136510
[TBL] [Abstract][Full Text] [Related]
19. X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals.
Qi S; Al Mamun A; Ngwa C; Romana S; Ritzel R; Arnold AP; McCullough LD; Liu F
J Neuroinflammation; 2021 Mar; 18(1):70. PubMed ID: 33712031
[TBL] [Abstract][Full Text] [Related]
20. Demethylase Kdm6a epigenetically promotes IL-6 and IFN-β production in macrophages.
Li X; Zhang Q; Shi Q; Liu Y; Zhao K; Shen Q; Shi Y; Liu X; Wang C; Li N; Ma Y; Cao X
J Autoimmun; 2017 Jun; 80():85-94. PubMed ID: 28284523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
